Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)

V. Stefoni, C. Pellegrini, A. Broccoli, L. Baldini, M. Tani, E. Cencini, A. Figuera, M. Ansuinelli, E. Bernocco, M. Cantonetti, M.C. Cox, F. Ballerini, C. Rusconi, C. Visco, L. Arcaini, A. Fama, R. Marasca, S. Volpetti, A. Castellino, C. CalifanoM. Cavaliere, G. Gini, A.M. Liberati, G. Musuraca, A. Lucania, G. Ricciuti, L. Argnani, P.L. Zinzani

Research output: Contribution to journalArticle

Cite this

Stefoni, V., Pellegrini, C., Broccoli, A., Baldini, L., Tani, M., Cencini, E., Figuera, A., Ansuinelli, M., Bernocco, E., Cantonetti, M., Cox, M. C., Ballerini, F., Rusconi, C., Visco, C., Arcaini, L., Fama, A., Marasca, R., Volpetti, S., Castellino, A., ... Zinzani, P. L. (2018). Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study). Oncologist, 23(9), 1033-1038. https://doi.org/10.1634/theoncologist.2017-0597